Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Proc Natl Acad Sci U S A ; 103(3): 726-31, 2006 Jan 17.
Article in English | MEDLINE | ID: mdl-16407097

ABSTRACT

A better understanding of the molecular basis of programmed cell death (PCD) in fungi could provide information that is useful in the design of antifungal drugs that combat life-threatening fungal infections. Harsh environmental stresses, such as acetic acid or hydrogen peroxide, have been shown to induce PCD in the pathogenic fungus Candida albicans. In this study, we show that dying cells progress from an apoptotic state to a secondary necrotic state and that the rate at which this change occurs is proportional to the intensity of the stimulus. Also, we found that the temporal response is modulated by Ras-cAMP-PKA signals. Mutations that block Ras-cAMP-PKA signaling (ras1Delta, cdc35Delta, tpk1Delta, and tpk2Delta) suppress or delay the apoptotic response, whereas mutations that stimulate signaling (RAS1(val13) and pde2Delta) accelerate the rate of entry of cells into apoptosis. Pharmacological stimulation or inhibition of Ras signaling reinforces these findings. Transient increases in endogenous cAMP occur under conditions that stimulate apoptosis but not growth arrest. Death-specific changes in the abundance of different isoforms of the PKA regulatory subunit, Bcy1p, are also observed. Activation of Ras signals may regulate PCD of C. albicans, either by inhibiting antiapoptotic functions (such as stress responses) or by activating proapoptotic functions.


Subject(s)
Apoptosis/physiology , Candida albicans/cytology , Candida albicans/pathogenicity , Signal Transduction/physiology , ras Proteins/physiology , Adenylyl Cyclases/genetics , Adenylyl Cyclases/metabolism , Candida albicans/metabolism , Cyclic AMP/metabolism , Mutation , Necrosis , ras Proteins/genetics
2.
Mol Microbiol ; 47(6): 1637-51, 2003 Mar.
Article in English | MEDLINE | ID: mdl-12622818

ABSTRACT

Several microbial pathogens augment their invasive potential by binding and activating human plasminogen to generate the proteolytic enzyme plasmin. Yeast cells and cell wall proteins (CWP) of the human pathogenic fungus Candida albicans bound plasminogen with a K(d) of 70 +/- 11 nM and 112 +/- 20 nM respectively. Bound plasminogen could be activated to plasmin by mammalian plasminogen activators; no C. albicans plasminogen activator was detected. Binding of plasminogen to CWP and whole cells was inhibited by epsilon ACA, indicating that binding was predominantly to lysine residues. Candida albicans mutant strains defective in protein glycosylation did not show altered plasminogen binding, suggesting that binding was not mediated via a surface lectin. Binding was sensitive to digestion by basic carboxypeptidase, implicating C-terminal lysine residues in binding. Proteomic analysis identified eight major plasminogen-binding proteins in isolated CWP. Five of these (phosphoglycerate mutase, alcohol dehydrogenase, thioredoxin peroxidase, catalase, transcription elongation factor) had C-terminal lysine residues and three (glyceraldehyde-3-phosphate dehydrogenase, phosphoglycerate kinase and fructose bisphosphate aldolase) did not. Activation of plasminogen could potentially increase the capacity of this pathogenic fungus for tissue invasion and necrosis. Although surface-bound plasmin(ogen) degraded fibrin, no direct evidence for a role in invasion of endothelial matrix or in penetration and damage of endothelial cells was found.


Subject(s)
Candida albicans/metabolism , Fungal Proteins/analysis , Fungal Proteins/metabolism , Plasminogen/metabolism , Aminocaproic Acid/pharmacology , Binding, Competitive/drug effects , Binding, Competitive/physiology , Candida albicans/drug effects , Cell Wall/metabolism , Electrophoresis, Gel, Two-Dimensional/methods , Fibrinolysin/metabolism , Fluorescein-5-isothiocyanate/metabolism , Fluorescent Dyes/metabolism , Humans , Mass Spectrometry/methods , Plasminogen/pharmacology , Protein Binding/drug effects , Protein Binding/physiology , Tissue Plasminogen Activator/antagonists & inhibitors , Tissue Plasminogen Activator/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...